Biotherapies developed and manufactured in France in compliance with good practices

Clinical studies based on real animal treatments
Easy to use products, delivered solely by veterinarians
Précédent
Suivant

Pipeline

Pipeline

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

CANIPREN

VBX-01
Canine osteoarthritis

VBX-03
Atopic dermatitis

VBX-06
Chronic
Inflammatory
Bowel
Disease

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

FELIPREN

VBZ-02
Gingivostomatitis

VBZ-07
Chronic kidney
failure

VBZ-01
Feline arthrosis

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

EQUIPREN
OMBISTEM

VBY-01
Equine arthrosis

Our Products

Our products

Discover the effects of mesenchymal stem cells on inflammatory and immune diseases developed by Vetbiobank

Further Developments

Nos autres développements?

Vetbiobank has developed a bank of cryopreserved equine amniotic membrane grafts; they are qualified in the same way as equine neonatal cells, and are being tested in compassionate situations to assist in the healing of corneal ulcers, lacerationsKor wounds in horses, dogs or cats that do not respond to conventional treatments.

Vetbiobank is developing a placental blood-based serum whose safety and efficacy has been tested by a VetAgro-Sup research team in a pilot clinical trial in horses with refractory corneal ulcers.

Vetbiobank for several years, has been conducting a research program on the secretion of bioactive molecules and particles by stem cells. Given the scope of the program, our R&D teams have set up key partnerships with academic research teams to characterize these capacities and to evaluate the opportunity to develop an acellular drug.

To learn more about the availability of these products

To learn more about the availability of these products

NEW INDICATIONS

The scientific literature shows that the potential application of mesenchymal stem cells could be extended to other indications than those currently explored by Vetbiobank such as degeneration of the intervertebral disc; Anti-infectious role; IBD; Dry keratoconjunctivitis; Tendinitis; Diabetes. 

If you wish to evaluate other research programs concerning this then contact us.  

For Veterinarians only

For Veterinarians only

Ask your veterinarian for the price of a stem cell injection at his clinic.

Product Pipeline

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

CANIPREN

VBX-01
Canine osteoarthritis

CA0102
Atopic dermatitis

CA0103
Atopic dermatitis
Chronic
Inflammatory
Bowel
Disease

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

FELIPREN

FE0101
Gingivostomatitis

FE0102
Chronic kidney
failure

FE0103
Feline arthrosis

Range Product Development & optimization Proof of Concept Pilot study Industrialisation /
Manufacturing
Pivotal study Approval Marketing Launch

EQUIPREN
OMBISTEM

EQ0101
Equine arthrosis